DPP4 and heart failure: Personalized Medicine: Exploring the role of genetic factors in predicting response to DPP-4 inhibitors could lead to more personalized treatment approaches in heart failure patients, allowing for individualized selection of antidiabetic agents based on genetic predispositions.